Caricamento...
Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine
Limited data exist concerning the long-term (≥5 year) survival rates of patients with stage IIIB and IV non-small cell lung carcinoma (NSCLC) receiving chemotherapy. We aimed to determine the long-term results of cisplatin plus third-generation (vinorelbine or gemcitabine) cytotoxic chemotherapy in...
Salvato in:
Autori principali: | , , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
D.A. Spandidos
2012
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3494120/ https://ncbi.nlm.nih.gov/pubmed/23226770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.714 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|